Corbus Pharmaceuticals Holdings, Inc.
USD7.54
-0.21 (-2.71%)
CEO
Yuval Cohen
IPO Date
2014-10-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.62
Prev. Close
$7.75
Day Low
$7.12
Day High
$7.68
52W Low
$6.72
52W High
$20.56
Market Cap
$0.09B
Volume
0.84M
| 192,300 |
| $11.51 |
| 22 May 2026 | Saxena Nishant C | Chief Business Officer | Disposed | 0 | $0.00 |
| 21 May 2026 | Kung Winston | director | A-Award | Acquired | 3,800 | $0.00 |
| 21 May 2026 | Kung Winston | director | A-Award | Acquired | 12,300 | $9.15 |
| 21 May 2026 | Jacques Rachelle Suzanne | director | A-Award | Acquired | 3,800 | $0.00 |
| 21 May 2026 | Jacques Rachelle Suzanne | director | A-Award | Acquired | 12,300 | $9.15 |
| 21 May 2026 | Jenkins John Kenneth | director | A-Award | Acquired | 3,800 | $0.00 |
| 21 May 2026 | Jenkins John Kenneth | director | A-Award | Acquired | 12,300 | $9.15 |
| 21 May 2026 | Altmeyer Anne | director | A-Award | Acquired | 3,800 | $0.00 |